International Journal of Drug Policy
Volume 19, Issue 5 , Pages 393-400 , October 2008

Maximising the highs and minimising the lows: Harm reduction guidance within ecstasy distribution networks

  • Camille Jacinto

      Affiliations

    • Institute for Scientific Analysis, 390 Fourth Street, 2nd Floor, Suite D, San Francisco, CA 94107, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 415 777 2352; fax: +1 415 563 9940.
    • ,
  • Micheline Duterte

      Affiliations

    • Institute for Scientific Analysis, 390 Fourth Street, 2nd Floor, Suite D, San Francisco, CA 94107, United States
    • ,
  • Paloma Sales

      Affiliations

    • Institute for Scientific Analysis, 390 Fourth Street, 2nd Floor, Suite D, San Francisco, CA 94107, United States
    • ,
  • Sheigla Murphy

      Affiliations

    • Centre for Substance Abuse Studies, Institute for Scientific Analysis, 390 Fourth Street, 2nd Floor, Suite D, San Francisco, CA 94107, United States

Received 4 April 2007 ,Revised 28 August 2007 ,Accepted 4 September 2007.

References 

  1. Allott K, Redman J. Patterns of use and harm reduction practices of ecstasy users in Australia. Drug and Alcohol Dependence. 2006;82:168–176
  2. Baggot M. Preventing problems in ecstasy users: Reduce use to reduce harm. Journal of Psychoactive Drugs. 2002;34:145–162
  3. Beck J, Rosenbaum M. Pursuit of ecstasy: The MDMA experience. Albany: State University of New York Press; 1994;
  4. Becker H. Outsiders: Studies in the sociology of deviance. New York: Free Press; 1963;
  5. Biernacki P, Waldorf D. Snowball sampling: Problems, techniques and chain-referral sampling. Sociological Methods and Research. 1981;10(2):141–163
  6. Birdsall T. 5-Hydrotryptophan: A clinically-effective serotonin precursor. Alternative Medicine Review. 1998;3(4):271–280
  7. Buroway M, Burton A, Ferguson A, Fox K, Gamson J, Gartrell N, et al. Ethnography unbound: Power and resistance in the modern metropolis. Berkeley and Los Angeles, CA: University of California Press; 1991;
  8. Carlson RG, Falck RA, McCaughan JA, Siegal HA. MDMA/Ecstasy use among young people in Ohio: Perceived risk and barriers to intervention. Journal of Psychoactive Drugs. 2004;36(2):181–189
  9. Charmaz K. Contemporary field research. In:  Emerson R editors. Contemporary field research. Boston: Little-Brown; 1983;p. 109–126
  10. Copeland J, Dillon P, Gascoigne M. Ecstasy and the concomitant use of pharmaceuticals. Addictive Behaviors. 2006;31:367–370
  11. Cottler LB, Womack SB, Compton WM. Ecstasy abuse and dependence: Applicability and reliability of DSM-IV criteria among adolescents and young adults. Human Psychopharmacology. 2001;16:599–606
  12. Curran HV, Travill RA. Mood and cognitive effects of ±3,4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’): Week-end ‘high’ followed by mid-week low. Addiction. 1997;92(7):821–831
  13. Erowid (2001, December). Do antioxidants protect against MDMA hangover, tolerance and neurotoxicity? Erowid Extracts, 2: 6–11. Retrieved from http://www.erowid.org/chemicals/mdma/mdma_article3.shtml.
  14. Falck RS, Carlson RG, Wang J, Siegal HA. Sources of information about MDMA (3,4-methylenedioxymethamphetamine): Perceived accuracy, importance, and implications for prevention among young adult users. Drug and Alcohol Dependence. 2004;74(1):45–54
  15. Gamma A, Jerome L, Liechti ME, Lumnall HR. Is ecstasy perceived to be safe? A critical survey. Drug and Alcohol Dependence. 2005;77(2):185–193
  16. Glaser B, Strauss A. The discovery of grounded theory. Chicago: Aldine; 1967;
  17. Gourley M. A subcultural study of recreational ecstasy use. Journal of Sociology. 2004;40(1):59–73
  18. Hansen D, Maycock B, Lower T. ‘Weddings, parties, anything...’, A qualitative analysis of ecstasy use in Perth, Western Australia. International Journal of Drug Policy. 2001;12:181–199
  19. Hinchcliff S. The meaning of ecstasy use and clubbing to women in the late 1990s. International Journal of Drug Policy. 2001;12:455–468
  20. Hunt GP, Evans K, Kares F. Drug use and meanings of risk and pleasure. Journal of Youth Studies. 2007;10(1):73–96
  21. Jacinto, C., Duterte, M., Sales, P., & Murphy, S. (2008). ‘I’m not a real dealer’: The identity process of Ecstasy sellers. Journal of Drug Issues, in press.
  22. Kuzel A. Sampling in qualitative inquiry. In:  Crabtree BF,  Miller WL editor. Doing qualitative research. Newbury Park, CA: Sage; 1992;p. 31–45
  23. Lieb R, Schuetz CG, Pfister H, von Sydow K, Wittchen H. Mental disorders in ecstasy users: A prospective longitudinal investigation. Drug and Alcohol Dependence. 2002;68:195–207
  24. MacInnes N, Handley SL, Harding GFA. Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms. Journal of Psychopharmacology. 2001;15(3):181–186
  25. Measham F, Aldridge J, Parker H. Dancing on drugs: Risks, health and hedonism in the British Club Scene. London: Free Association Books; 2001;
  26. Murphy PN, Wareing M, Fisk JE. Users’ perceptions of the risks and effects of taking ecstasy (MDMA): A questionnaire study. Journal of Psychopharmacology. 2006;20(3):447–455
  27. Parrott AC. Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine). Journal of Psychopharmacology. 2005;19(1):75–87
  28. Parrott AC, Lasky J. Ecstasy (MDMA) effects upon mood and cognition: Before, during and after a Saturday night dance. Psychopharmacology. 1998;139:261–269
  29. Rodgers J, Buchanan T, Pearson C, Parrott AC, Ling J, Heffernan T, et al. Differential experiences of the psychobiological sequelae of ecstasy use: Quantitative and qualitative data from an internet study. Journal of Psychopharmacology. 2006;20(3):437–446
  30. Schensul JJ, Diamond S, Disch W, Bermudez R, Eiserman J. The diffusion of ecstasy through urban youth networks. Journal of Ethnicity in Substance Abuse. 2005;4(2):39–71
  31. Shewan D, Dalgarno P, Reith G. Perceived risk and risk reduction among ecstasy users: The role of drug, set and setting. International Journal of Drug Policy. 2000;10:431–453
  32. Soar K, Turner JJD, Parrott AC. Problematic versus non-problematic ecstasy/MDMA use: The influence of drug usage patterns and pre-existing psychiatric factors. Journal of Psychopharmacology. 2006;20(3):417–424
  33. Southgate E, Hopwood M. The role of folk pharmacology and lay experts in harm reduction: Sydney gay drug using networks. International Journal of Drug Policy. 2001;12:321–335
  34. Sprague JE, Huang X, Kanthasamy A, Nichols DE. Attenuation of 3,4 methylenedioxymethamphetamine (MDMA) induced neurotoxicity with the serotonin precursors tryptophan and 5-hydroxytryptophan. Life Science. 1994;55(15):1193–1198
  35. Strauss A, Corbin J. Basics of qualitative research. Newbury Park, CA: Sage Publications; 1990;
  36. Verheyden SL, Maidment R, Curran HV. Quitting ecstasy: An investigation of why people stop taking the drug and their subsequent mental health. Journal of Psychopharmacology. 2003;17(4):371–378
  37. Watters J, Biernacki P. Targeted sampling: Options for the study of hidden populations. Social Problems. 1989;36(4):416–430
  38. Weir E. Raves: A review of the culture, the drugs and the prevention of harm. Canadian Medical Association Journal. 2000;162(13):1843–1848
  39. White B, Degenhardt L, Breen C, Bruno R, Newman J, Proudfoot P. Risk and benefit perception of party drug use. Addictive Behaviors. 2006;31:137–142
  40. Zinberg NE. Drug, set and setting: The basis for controlled intoxicant use. New Haven, CT: Yale University Press; 1984;

PII: S0955-3959(07)00208-3

doi: 10.1016/j.drugpo.2007.09.003

International Journal of Drug Policy
Volume 19, Issue 5 , Pages 393-400 , October 2008

Article Tools